Literature DB >> 7693595

Outer membrane protein binding sites of complement component 3 during opsonization of Haemophilus influenzae.

S V Hetherington1, C C Patrick, E J Hansen.   

Abstract

Complement component 3 (C3) binding to Haemophilus influenzae type b (Hib) is an important step in host defense against invasive disease, but the details of this process remain poorly understood. We have shown that the P1 and P2 outer membrane proteins (OMPs) serve as binding sites for C3 on serum-opsonized Hib. Whole-cell lysates of opsonized Hib were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the resolved proteins were transferred to nitrocellulose. Immunoblot analysis with monoclonal antibodies (MAbs) to the 49-kDa P1 and 39-kDa P2 OMPs demonstrated high-molecular-weight bands that were not present when the bacteria were opsonized with heat-inactivated or methylamine-treated serum. Immunoblot analysis with MAbs to the 98- or 16-kDa (P6) OMPs did not reveal additional bands. An unencapsulated Hib mutant still lacked C3 bound to the 98-kDa or P6 OMP, indicating that the absence of C3 binding to these proteins was not the result of epitope masking by the capsule. Studies with MAbs to C3 fragments confirmed that the anti-P1- and anti-P2-reactive bands were C3 fragments bound to these OMPs. The molecular weights of proteins reactive to anti-OMP and anti-C3 antibodies indicated that multiple C3 fragments may be bound to P1 or that C3 may be bound to P2 multimers. Finally, the presence of other anti-C3-reactive proteins indicated that several other proteins serve as C3 targets during the opsonization of Hib.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693595      PMCID: PMC281296          DOI: 10.1128/iai.61.12.5157-5163.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis.

Authors:  F J Crosson; J A Winkelstein; E R Moxon
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

2.  Specificity of three anti-complement factor 3 monoclonal antibodies.

Authors:  S Henwick; S V Hetherington; M K Hostetter
Journal:  J Immunol Methods       Date:  1992-08-30       Impact factor: 2.303

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

Review 4.  Systemic Haemophilus influenzae disease: an overview.

Authors:  A S Dajani; B I Asmar; M C Thirumoorthi
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

5.  Experimental Haemophilus influenzae type b meningitis: immunological investigation of the infant rat model.

Authors:  D M Granoff; R Rockwell
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

6.  Detection of antibody-accessible proteins on the cell surface of Haemophilus influenzae type b.

Authors:  E J Hansen; C F Frisch; K H Johnston
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

7.  Target antigens for bactericidal and opsonizing antibodies to Haemophilus influenzae.

Authors:  T Dahlberg-Lagergård
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1982-08

8.  The isolation of IgG from mammalian sera with the aid of caprylic acid.

Authors:  M Steinbuch; R Audran
Journal:  Arch Biochem Biophys       Date:  1969-11       Impact factor: 4.013

9.  The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity.

Authors:  S Shaw; A L Smith; P Anderson; D H Smith
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

10.  Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia.

Authors:  J L Shenep; R S Munson; S J Barenkamp; D M Granoff
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

View more
  2 in total

1.  Two-component systems in Haemophilus influenzae: a regulatory role for ArcA in serum resistance.

Authors:  J A De Souza-Hart; W Blackstock; V Di Modugno; I B Holland; M Kok
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  DNA sequence analysis and restriction fragment length polymorphisms of the P1 gene of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever.

Authors:  R B Reed; J B Frost; K Kort; S D Myers; A J Lesse
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.